Adiponectin, a cytokine generated by adipocytes, has been demonstrated to exert insulin-sensitizing, anti-inflammatory, and anti-atherogenic properties [7–10], which is suggested to serve as a potential biomarker for the risk of CVDs [11,12], including AF. This evidence concerns the gene ADIPOQ and atrial fibrillation.